We are on a path of expansion which is reflected through our acquisition of a manufacturing facility in Gujarat and completion of our biosimilar facility in Chennai. Commercialization of the biosimilar range is expected in Q3 2022. Additionally, we have now opened three new offices in Spain, UAE, and Costa Rica in order to expand our reach and range in the regions.
Our Journey from humble beginnings
to our proud heritage, Our story began in 1968.
1968
Prime Group starts as an API company in Kolkata.
2005
Forays into the FDF export business and plans to expand internationally.
2007
Enters the African Markets.
2010
Enters the South East Asian Markets.
2012
Enters the Latin & Central American Markets.
2016
Officially starts its first global office in Vietnam and sets up the R&D Service vertical.
2020
Invests into Regenix Group to set up a greenfield EU Compliant biosimilars facility and expands it's footprint into 50+ countries globally
2021
Acquires a pharma company with an FDF plant in India and opens global offices in UAE, Spain, and Costa Rica.
Moving Forward
Prime Pharmaceuticals Pvt. Ltd
B327/328, 3rd Floor,
Chintamani Plaza,
Andheri Kurla Road,
Andheri (East),
Mumbai 400099, INDIA.